Open AccessEfficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia
Author(s) -
Myrto Samara,
Markus Dold,
Myrsini Gianatsi,
Adriani Nikolakopoulou,
Bartosz Helfer,
Georgia Salanti,
Stefan Leucht
Publication year - 2016
Publication title -
jama psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.531
H-Index - 365
eISSN - 2168-6238
pISSN - 2168-622X
DOI - 10.1001/jamapsychiatry.2015.2955
Subject(s) - tolerability , schizophrenia (object oriented programming) , medicine , psychiatry , psychology , adverse effect
In treatment-resistant schizophrenia, clozapine is considered the standard treatment. However, clozapine use has restrictions owing to its many adverse effects. Moreover, an increasing number of randomized clinical trials (RCTs) of other antipsychotics have been published.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom